Novel Coronavirus Disease 2019 (COVID-19): A Focused Clinic Overview |Biomedgrid

At the end of 2019, a series of COVID-19 related respiratory infections were initially identified in China. After a few months of spreading via human-to-human transmission, it has been rapidly outbreak over 200 countries worldwide, becoming an emergency of primary international concern and posing a severe threat to public health globally. COVID-19 infection can cause clusters of symptoms from mild influenza-like illness to the severe acute respiratory syndrome. A better understanding of clinical symptoms, risk factors, and clinic progression will benefit disease control. This literature review demonstrates the clinical course of COVID-19, including risk factors, clinical presentation, progression and complication.